A journal has retracted a paper about a molecular diagnosis for leishmaniasis out of concern it could lead to incorrect clinical diagnoses.
According to Parasitology Research, all data behind the figures in the main manuscript and supporting information are correct, but the authors’ misinterpretation of the data could lead doctors to diagnose patients incorrectly.
The journal Epidemiology Biostatistics and Public Health has issued back-to-back corrections for a 2015 paper after the authors failed to disclose conflicts of interest with the asbestos industry and included an “erroneous citation.”
The mistaken citation was more than just a clerical error, critics argue — it undermines one of the key arguments of the paper, “Critical reappraisal of Balangero chrysotile and mesothelioma risk,” which disputes claims that an asbestos mine in northwest Italy was responsible for numerous cases of an aggressive form of cancer called mesothelioma. The authors, led by Edward Ilgren formerly of Oxford University, claim that “myriad sources” of other forms of asbestos—rather than the asbestos produced at the mine, called chrysotile—exist in the region “to account for the alleged cases.”
However, according to a recently added correction, the citation does not support one of the authors’ claims about how other forms of asbestos arrived at the mine area.
The list of co-authors on a paper about a “bioelectronic composite” was apparently too sparse.
According to its retraction note — posted at the request of the editor-in-chief and the corresponding author — the paper failed to include some of the collaborators.
The Biosensors & Bioelectronics paper looks at a protein complex that could function as part of a “bio-hybrid” device, like a sensor or a solar cell. It has been cited only by its retraction according to Thomson Reuters Web of Science.
What went wrong in allotting credit for the work pretty straightforward, according to the note for “Monolayers of pigment–protein complexes on a bare gold electrode: Orientation controlled deposition and comparison of electron transfer rate for two configurations.” Here it is in full:
Are individual scientists now more productive early in their careers than 100 years ago? No, according to a large analysis of publication records released by PLOS ONE today.
Despite concerns of rising “salami slicing” in research papers in line with the “publish or perish” philosophy of academic publishing, the study found that individual early career researchers’ productivity has not increased in the last century. The authors analyzed more than 760,000 papers of all disciplines published by 41,427 authors between 1900 and 2013, cataloged by Thomson Reuters Web of Science.
The authors summarize their conclusions in “Researchers’ individual publication rate has not increased in a century:”
After temporarily removing a paper that suggested a link between the vaccine for the human papillomavirus (HPV) and behavioral issues, the journal has now retracted it.
Vaccine says the reason is “serious concerns regarding the scientific soundness of the article,” including flawed methodology and unjustified claims.
Christopher A. Shaw, a co-author on the paper and a researcher at the University of British Columbia, told us he has seen the notice, but doesn’t know the specific issues the journal had with the paper:
We still don’t know why [Editor in Chief] Dr Poland removed the article.
Here’s the retraction notice for “Behavioral abnormalities in young female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil:”
A Toronto hospital network is keeping two researchers’ labs closed even after an Ontario court quashed part of a misconduct finding by the institution.
According to the Toronto Star, on February 4th the UHN notified the researchers that the sanction against them would be upheld, and it would not reopen the researchers’ labs.
The editor in chief of Vaccine has removed a paper suggesting a human papillomavirus (HPV) vaccine can trigger behavioral changes in mice.
The note doesn’t provide any reason for the withdrawal, although authors were told the editor asked for further review.
Two co-authors on the paper — about Gardasil, a vaccine against HPV — have previously suggested that aluminum in vaccines is linked to autism, in research a World Health Organization advisory body concluded was “seriously flawed.”
Approximately 80 million doses of Gardasil were administered in the U.S. between 2006 and 2015. Both the the WHO and the Centers for Disease Control and Prevention have ruled the vaccine to be safe — the CDC, for instance, calls it “safe, effective, and recommended.”
If audits work for the Internal Revenue Service, could they also work for science? We’re pleased to present a guest post from Viraj Mane, a life sciences commercialization manager in Toronto, and Amy Lossie at the National Institutes of Health, who have a unique proposal for how to improve the quality of papers: Random audits of manuscripts.
Skim articles, books, documentaries, or movies about Steve Jobs and you’ll see that ruthlessness is the sine qua non of some of our greatest business leaders. It would be naïve to assume that scientists somehow resist these universal impulses toward leadership, competition, and recognition. In the white-hot field of stem cell therapy, where promising discoveries attract millions of dollars, egregious lapses in judgment and honesty have been uncovered in Japan, Germany, and South Korea. The nature of the offenses ranged from fraudulent (plagiarism and duplication of figures) to horrifying (female subordinates coerced into donating their eggs).
When a researcher embraces deception, the consequences extend well beyond the involved parties. Former physician Andrew Wakefield published a linkage between MMR vaccines and autism with overtly substandard statistical and experimental methods, while hiding how his financial compensation was tied to the very hysteria he helped unleash.
On Friday Sunday, the Toronto Star reported that the court had set aside the finding of falsification, but upheld a finding of misconduct in the form of material non-compliance. It asked UHN to review the sanctions against both researchers, and cover their legal fees of $20,000.
A journal has retracted a paper about a molecular diagnosis for leishmaniasis out of concern it could lead to incorrect clinical diagnoses. 
